Moody Lynn & Lieberson’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $997K | Sell |
2,753
-9,613
| -78% | -$3.29M | 0.05% | 124 |
|
|
2026
Q1 | $4.35M | Sell |
12,366
-689
| -5% | -$246K | 0.24% | 54 |
|
|
2025
Q4 | $4.27M | Buy |
13,055
+10,301
| +374% | +$3.27M | 0.23% | 61 |
|
|
2025
Q3 | $777K | Sell |
2,754
-37
| -1% | -$10.7K | 0.04% | 137 |
|
|
2025
Q2 | $779K | Sell |
2,791
-12,158
| -81% | -$3.44M | 0.05% | 136 |
|
|
2025
Q1 | $4.66M | Buy |
14,949
+12,210
| +446% | +$3.61M | 0.3% | 54 |
|
|
2024
Q4 | $714K | Sell |
2,739
-580
| -17% | -$172K | 0.04% | 142 |
|
|
2024
Q3 | $1.07M | Sell |
3,319
-10,593
| -76% | -$3.47M | 0.07% | 124 |
|
|
2024
Q2 | $4.35M | Buy |
13,912
+11,070
| +390% | +$3.25M | 0.28% | 55 |
|
|
2024
Q1 | $808K | Hold |
2,842
| – | – | 0.05% | 126 |
|
|
2023
Q4 | $819K | Hold |
2,842
| – | – | 0.06% | 128 |
|
|
2023
Q3 | $764K | Sell |
2,842
-107
| -4% | -$26.7K | 0.07% | 119 |
|
|
2023
Q2 | $655K | Buy |
2,949
+1,270
| +76% | +$295K | 0.05% | 133 |
|
|
2023
Q1 | $406K | Sell |
1,679
-11,675
| -87% | -$2.87M | 0.04% | 169 |
|
|
2022
Q4 | $3.51M | Buy |
13,354
+11,675
| +695% | +$3.13M | 0.32% | 64 |
|
|
2022
Q3 | $378K | Hold |
1,679
| – | – | 0.04% | 168 |
|
|
2022
Q2 | $409K | Buy |
1,679
+195
| +13% | +$47.8K | 0.04% | 165 |
|
|
2022
Q1 | $359K | Hold |
1,484
| – | – | 0.03% | 184 |
|
|
2021
Q4 | $334K | Hold |
1,484
| – | – | 0.02% | 198 |
|
|
2021
Q3 | $316K | Sell |
1,484
-20
| -1% | -$4.6K | 0.02% | 189 |
|
|
2021
Q2 | $367K | Sell |
1,504
-61
| -4% | -$15K | 0.03% | 177 |
|
|
2021
Q1 | $389K | Buy |
1,565
+40
| +3% | +$9.54K | 0.03% | 174 |
|
|
2020
Q4 | $351K | Hold |
1,525
| – | – | 0.03% | 169 |
|
|
2020
Q3 | $388K | Hold |
1,525
| – | – | 0.04% | 150 |
|
|
2020
Q2 | $360K | Hold |
1,525
| – | – | 0.04% | 144 |
|
|
2020
Q1 | $309 | Sell |
1,525
-21,574
| -93% | -$4.71M | 0.04% | 133 |
|
|
2019
Q4 | $5.57M | Buy |
+23,099
| New | +$5.09M | 0.54% | 56 |
|
|
2019
Q1 | – | Sell |
-44,467
| Closed | -$8.66M | – | 187 |
|
|
2018
Q4 | $8.66M | Buy |
44,467
+20,767
| +88% | +$4.05M | 1.16% | 28 |
|
|
2018
Q3 | $4.91M | Buy |
23,700
+19,665
| +487% | +$3.88M | 0.52% | 61 |
|
|
2018
Q2 | $745K | Buy |
+4,035
| New | +$714K | 0.09% | 119 |
|
|
2017
Q4 | – | Sell |
-12,620
| Closed | -$2.35M | – | 208 |
|
|
2017
Q3 | $2.35M | Buy |
+12,620
| New | +$2.24M | 0.29% | 71 |
|
|
2017
Q2 | – | Sell |
-37,640
| Closed | -$6.18M | – | 213 |
|
|
2017
Q1 | $6.18M | Buy |
37,640
+7,610
| +25% | +$1.26M | 0.87% | 45 |
|
|
2016
Q4 | $4.39M | Sell |
30,030
-33,513
| -53% | -$5.04M | 0.63% | 50 |
|
|
2016
Q3 | $10.6M | Buy |
+63,543
| New | +$10.7M | 1.76% | 15 |
|
|
2016
Q1 | – | Sell |
-46,292
| Closed | -$7.51M | – | 160 |
|
|
2015
Q4 | $7.51M | Buy |
46,292
+43,493
| +1,554% | +$6.84M | 1.18% | 28 |
|
|
2015
Q3 | $387K | Buy |
+2,799
| New | +$441K | 0.07% | 129 |
|
|
2015
Q2 | – | Sell |
-117,975
| Closed | -$18.9M | – | 191 |
|
|
2015
Q1 | $18.9M | Sell |
117,975
-1,735
| -1% | -$273K | 3.01% | 5 |
|
|
2014
Q4 | $19.1M | Sell |
119,710
-2,903
| -2% | -$452K | 2.72% | 4 |
|
|
2014
Q3 | $17.2M | Buy |
122,613
+58,139
| +90% | +$7.59M | 2.56% | 6 |
|
|
2014
Q2 | $7.63M | Buy |
64,474
+7,780
| +14% | +$901K | 1.05% | 39 |
|
|
2014
Q1 | $6.99M | Sell |
56,694
-3,236
| -5% | -$392K | 1.01% | 39 |
|
|
2013
Q4 | $6.84M | Buy |
59,930
+959
| +2% | +$109K | 0.93% | 42 |
|
|
2013
Q3 | $6.6M | Buy |
58,971
+17,511
| +42% | +$1.9M | 1.02% | 39 |
|
|
2013
Q2 | $4.09M | Buy |
+41,460
| New | +$4.3M | 0.72% | 53 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Moody Lynn & Lieberson's AMGN Position: Q2 2026 in Review
Moody Lynn & Lieberson reduced its Amgen (AMGN) stake by 78% in Q2 2026, selling an estimated $3.29M and leaving 2,753 shares worth $997K. The position accounts for 0.05% of the portfolio, ranked #124.
Moody Lynn & Lieberson first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $19.1M in Q4 2014. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Moody Lynn & Lieberson held 2,753 shares of Amgen worth $997K as of Q2 2026.
- Moody Lynn & Lieberson sold 9,613 Amgen shares in Q2 2026, an estimated $3.29M.
- Amgen made up 0.05% of Moody Lynn & Lieberson's portfolio in Q2 2026, its #124 holding.
- Moody Lynn & Lieberson first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
- Moody Lynn & Lieberson's Amgen position peaked at $19.1M in Q4 2014.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.